Hydrolytic and Free Radical Mediated DNA Damage
Hydrolytic and Free Radical Mediated DNA Damage
批准号:
7046891
负责人:
Lawrence C Sowers
金额:
$24.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 2009-02-28
关键词:
5 methylcytosineDNA binding proteinDNA damageDNA methylationDNA repairN glycosidaseaffinity chromatographycarcinogenschemical kineticschromosome deletionenzyme activityfree radicalsgene mutationgene rearrangementhigh performance liquid chromatographyhuman tissuehydrolysismass spectrometrymutagensneoplastic celloxidationpyrimidinesradiation related neoplasm /canceruracil analog
中文摘要
描述(由申请人提供):在过去的世纪,工业化国家的预期寿命急剧增加。预期寿命增加的一个后果是,通常与衰老有关的疾病,包括癌症和神经变性,将影响更多的人。癌症的遗传基础归因于一系列DNA损伤事件,包括点突变、染色体重排和丢失以及表观遗传变化,如DNA胞嘧啶甲基化模式改变。已知DNA会被外源性化学物质和辐射破坏。然而,即使在不存在外源性试剂的情况下,细胞DNA也会持续氧化、水解和甲基化。据估计,形成的内源性DNA损伤的数量为每天每个细胞数万个的数量级。为了应对DNA损伤,细胞有一个复杂的修复途径网络,可以识别、切除和重建受损部位。已知DNA修复途径的缺陷会大幅增加癌症的发病率。随着人类寿命的延长,DNA可能会受到损伤,再加上包括癌症在内的年龄相关疾病的增加,我们需要了解DNA是如何受损的,以及修复途径是如何发挥作用的。我们在这个项目上的工作重点是五种嘧啶氧化产物,这些产物可以由辐射、致癌物暴露和内源性DNA损伤引起。这些修饰的嘧啶包括5-羟甲基尿嘧啶(HmU)、5-甲酰基尿嘧啶(FoU)、5-羟甲基胞嘧啶(HmC)、5-羟基尿嘧啶(HoU)和5-羟基胞嘧啶(HoC)。在前期的资助中,我们发现了这些修饰的嘧啶的几个重要的化学性质,并且我们发现了细胞修复酶识别受损碱基的几个新的和重要的性质。在当前的提案中,我们描述了一系列实验来跟进这些发现。本发明的具体目的是:1)鉴定负责HmU修复的蛋白质,并进一步了解细胞对外源性HmU修复的反应,2)研究5-甲基胞嘧啶(5 mC)氧化的生化后果,包括HmC对DNA的影响。蛋白质相互作用并进一步研究甲基化模式可能通过其改变的潜在的新生化途径,3)鉴定受损嘧啶被DNA修复糖基化酶识别的一般机制,和4)开发用于鉴定和表征尚未鉴定的DNA修复蛋白的一般策略。这些研究的结果将为我们对DNA损伤及其修复的理解提供重要的新线索。有了这些新的见解,我们可以了解如何减少导致人类疾病(包括癌症)的DNA损伤,以及了解如何利用DNA修复途径中的缺陷或改变来开发更具选择性的化疗。
英文摘要
DESCRIPTION (provided by applicant): Life expectancy in the industrialized world has increased dramatically over the past century. A consequence of the increasing life expectancy is that diseases generally associated with aging, including cancer and neurodegeneration, will affect more individuals. The genetic basis of cancer is attributed to a series of DNA damage events that can include point mutations, chromosome rearrangements and loss, and epigenetic changes such as altered DNA cytosine methylation patterns. DNA is known to be damaged by exogenous chemicals and radiation. However, cellular DNA is continuously oxidized, hydrolyzed and methylated even in the absence of exogenous agents. It is estimated that the number of endogenous DNA lesions formed is on the order of tens of thousands per cell per day. In response to DNA damage, cells have a complex network of repair pathways that recognize, excise and rebuild the damaged sites. Defects in DNA repair pathways are known to increase substantially the incidence of cancer. An increase in human life span over which DNA can be damaged, coupled with an increase in age-associated diseases including cancer, highlight the need to understand how DNA can be damaged and how repair pathways function.The focus of our efforts on this project has been five pyrimidine oxidation products that can result from radiation, carcinogen exposure and endogenous DNA damage. These modified pyrimidines include 5-hydroxymethyluracil (HmU), 5-formyluracil (FoU), 5-hydroxymethylcytosine (HmC), 5-hydroxyuracil (HoU) and 5-hydroxycytosine (HoC). In the previous period of funding, we discovered several important chemical properties of these modified pyrimidines, and we have discovered several new and significant properties of damaged base recognition by cellular repair enzymes.In the current proposal, we describe a series of experiments to follow up on these findings. The specific aims of the current proposal are 1) to identify the proteins responsible for the repair of HmU and to further understand cellular responses to the repair of exogenous HmU, 2) to investigate biochemical consequences of the oxidation of 5- methylcytosine (5mC) including the impact of HmC on DNA-protein interactions and to further investigate a potential novel biochemical pathway through which methylation patterns might be altered, 3) to identify the general mechanisms by which damaged pyrimidines are recognized by DNA repair glycosylases, and 4) to develop a general strategy for the identification and characterization of as yet unidentified DNA repair proteins. The results of the proposed studies should shed significant new light on our understanding of DNA damage and its repair. With these added insights, we may learn how to reduce DNA damage that leads to human diseases including cancer, as well as understand how to exploit defects or alterations in DNA repair pathways for the development of more selective chemotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytosine Deamination Adducts and Cancer Etiology
-
批准号:10359784
-
项目类别:
-
资助金额:$40.64万
-
财政年份:2019
-
负责人:Lawrence C Sowers
-
依托单位:
Cytosine Deamination Adducts and Cancer Etiology
-
批准号:10592257
-
项目类别:
-
资助金额:$40.64万
-
财政年份:2019
-
负责人:Lawrence C Sowers
-
依托单位:
Oxidation of 5-methylcytosine: DNA damage and epigenetic reprogramming
-
批准号:8845531
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2014
-
负责人:Lawrence C Sowers
-
依托单位:
Damaged DNA Recognition as a Cancer Avoidance Mechanism
-
批准号:6990490
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2005
-
负责人:Lawrence C Sowers
-
依托单位:
Damaged DNA Recognition as a Cancer Avoidance Mechanism
-
批准号:7344834
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2005
-
负责人:Lawrence C Sowers
-
依托单位:
Damaged DNA Recognition as a Cancer Avoidance Mechanism
-
批准号:6861659
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2005
-
负责人:Lawrence C Sowers
-
依托单位:
Damaged DNA Recognition as a Cancer Avoidance Mechanism
-
批准号:7172331
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2005
-
负责人:Lawrence C Sowers
-
依托单位:
Chemical Pathology of 5-aza-2'-deoxycytidine
-
批准号:6909684
-
项目类别:
-
资助金额:$5.14万
-
财政年份:2003
-
负责人:Lawrence C Sowers
-
依托单位:
Chemical Pathology of 5-aza-2'-deoxycytidine
-
批准号:7082951
-
项目类别:
-
资助金额:$28.51万
-
财政年份:2003
-
负责人:Lawrence C Sowers
-
依托单位:
Chemical Pathology of 5-aza-2'-deoxycytidine
-
批准号:7077939
-
项目类别:
-
资助金额:$5.27万
-
财政年份:2003
-
负责人:Lawrence C Sowers
-
依托单位:
Chemical Pathology of 5-aza-2'-deoxycytidine
-
批准号:6761772
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2003
-
负责人:Lawrence C Sowers
-
依托单位:
Chemical Pathology of 5-aza-2'-deoxycytidine
-
批准号:7228673
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2003
-
负责人:Lawrence C Sowers
-
依托单位:
Chemical Pathology of 5-aza-2'-deoxycytidine
-
批准号:7228861
-
项目类别:
-
资助金额:$27.68万
-
财政年份:2003
-
负责人:Lawrence C Sowers
-
依托单位:
Chemical Pathology of 5-aza-2'-deoxycytidine
-
批准号:6897283
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2003
-
负责人:Lawrence C Sowers
-
依托单位:
Chemical Pathology of 5-aza-2'-deoxycytidine
-
批准号:6612095
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2003
-
负责人:Lawrence C Sowers
-
依托单位:
INFIDELITY OF CYTOSINE METHYLATION AND HUMAN CANCER
-
批准号:6042146
-
项目类别:
-
资助金额:$29.73万
-
财政年份:2000
-
负责人:Lawrence C Sowers
-
依托单位:
INFIDELITY OF CYTOSINE METHYLATION AND HUMAN CANCER
-
批准号:6514321
-
项目类别:
-
资助金额:$25.6万
-
财政年份:2000
-
负责人:Lawrence C Sowers
-
依托单位:
INFIDELITY OF CYTOSINE METHYLATION AND HUMAN CANCER
-
批准号:6633603
-
项目类别:
-
资助金额:$26.37万
-
财政年份:2000
-
负责人:Lawrence C Sowers
-
依托单位:
Infidelity of Cytosine Methylation and Human Cancer
-
批准号:7030323
-
项目类别:
-
资助金额:$26.89万
-
财政年份:2000
-
负责人:Lawrence C Sowers
-
依托单位:
Infidelity of Cytosine Methylation and Human Cancer
-
批准号:7220005
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2000
-
负责人:Lawrence C Sowers
-
依托单位:
海外基金